b'Our Community Membersat New HeightsA Homegrown Success Story Finds a NewHome at Fitzsimons Innovation CommunityAt Fitzsimons Innovation Community, we get extremely excitedWhile most organizations in this space have to purchase less-when new organizations put down roots on our campus. Butcomprehensive datasets from hospitals, RefinedScience, because sometimes, these new Community members arent reallyof their continued strong partnership with CU and the UCHealth new at all. We can explain. CU Innovations provides a path tohospital system is the only company that can bring three sets of commercialization for the breakthrough work coming out of thedata together for analysis. They use clinical data and purchased University of Colorado Anschutz Medical Campus. Its a way fordata much like other organizations do, but RefinedScience also new discoveries happening through the course of research andhas full access to the real-world data coming out of the UCHealth training to evolve into new organizations and make their waysystem, including access to patient samples. This is what allows to market. RefinedScience, a high-tech biosciences companythem to perform single-cell, multi-omics analysis, thereby that uses unique access to and analysis of specialized data tomonitoring exactly how each cell reacts and changes as its going inform drug development and discovery, is one of the newestthrough treatment. In business, such strong relationships with Community members on the Fitzsimons campus and a perfectacademic institutions are extremely rare, but when your company example of a CU Innovations success story.was born from that institution, suddenly the playing field is We spoke with the leadership team from RefinedScience aboutdifferent. Where other companies have a ten-year forecast for their move from CU Innovations Startup Foundry in Bioscience 1 getting drugs through trials and to market, RefinedScience is able to their new home in Bioscience 3. CEO Erik Johnson explainsto cut that to three or four years, getting much needed drugs into how RefinedScience is changing the way data is used to improvethe hands of patients sooner. patient outcomes. Basically what we do is bring together asJust because Fitzsimons Innovation Community is right across much data as we can using fully curated datasuites for a specificthe street from CU Innovations doesnt mean it was the disease. Its complicated work, but the insights were able toimmediate choice for the new RefinedScience headquarters. generate allow us to identify drugs that may not have goneThe leadership team looked at other cities like San Diego and through to commercialization yet and find the specific biomarkersCambridge, Massachusetts, known communities for life sciences that will allow them to work for patients who need them. Fromincubation and development, but when it came down to it, this deep data analysis, theyre able to design smarter clinicalFitzsimons Innovation Community was the perfect fit. It allowed trials that can move previously stalled drugs through thethem to remain close to the team of experts they consult with clinical stage and on to market where they can start helpingon the CU campus and to have custom lab space in the right size patients. With the proprietary technology theyve developed tofor their initial location, knowing that the room they need to grow do this, theyre shaving millions of dollars and multiple yearsis available to them when theyre ready. With new hires on the off the process.horizon, a location here in Colorado also gives them access to When RefinedScience started as part of CU Innovations, it wasthe highly educated talent pool our state is known for. Johnson seen as an aid for physicians making decisions in the clinic. Itsexplains it like this: We were born out of this University and we been incredible to be a part of RefinedScience as it has evolvedcontinue to have extremely strong ties to it. Weve obviously from a clinical decision support tool into a whole new precisionevolved and now have our own identity, too, but weve learned medicine platform and research organization. What started as athat bringing the best of academia and the best of industry small project is now its own entity making big impacts for clinicaltogether can create the best company, so we never want to lose trials and patient outcomes, Kevin Wehber, Senior Director ofour connection to the academia side. Product Operations, tells us. Precision is a key word in whatIn addition to the proximity to their academic partners, the RefinedScience does, as their skilled research team lead by ChiefRefinedScience leadership team mentions a list of other Innovation Officer Clay Smith, M.D., is able to create insights atFitzsimons Innovation Community amenities that solidify their the single-cell level.choice every day. The Fitzsimons team genuinely cares about 14Fitzsimons Innovation Community 2024 Annual Innovation Report'